Back to Agenda
Session 5: Patient Education
Session Chair(s)
Arnold Vulto, PharmD, PhD
Em. Professor of Hospital Pharmacy & Practical Therapeutics
Erasmus University Medical Center Rotterdam, Netherlands
Given the variety in information on biosmilars that can reach patients, it is important that patients will be guided to reliable sources of information. Patient involvement is an important factor in the multi-stakeholder approach to increase biosimilar acceptance. In this session different approaches will be presented, from bottom-up to top-down.
Speaker(s)
Introduction: Educational Needs of Stakeholders and Patients
Hillel P Cohen, PhD
Sandoz Inc., United States
Executive Director, Scientific Affairs
The Dutch Biosimilars Op Maat (BOM) Initiative - Tailor-made Education on Biosimilars
Arnold Vulto, PharmD, PhD
Erasmus University Medical Center Rotterdam, Netherlands
Em. Professor of Hospital Pharmacy & Practical Therapeutics
Enabling an NHS Research-Ready Workforce to Embrace the Biosimilars Boom
Gareth Powell
National Institute for Health Research (NIHR), United Kingdom
Business Development Officer
Enabling an NHS Research-Ready Workforce to Embrace the Biosimilars Boom
Natalie Wilson
National Institute for Health Research (NIHR), United Kingdom
Business Decvelopment Manager
Panel Discussion with all speakers
Robert Andrew Johnstone
The International Foundation for Integrated Care (IFIC), United Kingdom
Patient Representative
Have an account?